Skip to Main Content

Paper Details

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
0
2023
COVID, COVID-19, SARS-CoV-2, mRNA, multiple sclerosis, people, pwMS
Author NameAffiliation
Paola CavallaAzienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino
  • 1 - 1

Datasets

Release 1.2